Luminescence imaging in biomedical research has allowed new insights into the
architecture of pathological tissues, signalling networks and cell interactions, and is now …

Fluorescence imaging in the second near-infrared (NIR-II) window enables deep-tissue
imaging with high resolution and improved contrast by taking advantage of the reduced light …

The use of boron dipyrromethene (BODIPY) in biomedicine is reviewed. To open, its
synthesis and regulatory strategies are summarized, and inspiring cutting‐edge work in post …

Molecular fluorophores emitting in the second near‐infrared (NIR‐II, 1000–1700 nm)
window with strong optical harvesting and high quantum yields hold great potential for in …

Molecular fluorophores with the second near‐infrared (NIR‐II) emission hold great potential
for deep‐tissue bioimaging owing to their excellent biocompatibility and high resolution …

In recent years, BODIPY-based theranostics have increasingly been used in cancer therapy
and have achieved significant success. According to photochemical theories, the optical …

In vivo fluorescence imaging in the second near-infrared window (NIR-II) has been
considered as a promising technique for visualizing mammals. However, the definition of the …

Fluorescence imaging in the second near‐infrared window (NIR‐II, 1000–1700 nm) has
aroused immense attention for biomedical applications, offering exceptional advantages …

NIR-II phototherapeutic agents possess the advantages of NIR-II optical imaging and
phototherapy, which include high signal-to-noise ratio imaging and non-invasive treatment …

Achieving photothermal therapy (PTT) at ultralow laser power density is crucial for
minimizing photo‐damage and allowing for higher maximum permissible skin exposure …